MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.

Toll-like receptors (TLRs) play a central role in the recognition and response to microbial pathogens and in the maintenance and function of the epithelial barrier integrity in the gut. The protein MyD88 adaptor-like (Mal/TIRAP) serves as a bridge between TLR2/TLR4- and MyD88-mediated signaling to orchestrate downstream inflammatory responses. Whereas MyD88 has an essential function in the maintenance of intestinal homeostasis, a role for Mal in this context is less well described. Colitis was induced in wild-type (WT) and Mal-deficient (Mal(-/-)) mice by administration of dextran sodium sulfate (DSS). Colitis-associated cancer was induced by DSS and azoxymethane (AOM) treatment. Chimeric mice were generated by total body gamma irradiation followed by transplantation of bone marrow cells. In the DSS model of colon epithelial injury, Mal(-/-) mice developed increased inflammation and severity of colitis relative to WT mice. Mal(-/-) mice demonstrated the presence of inflammatory cell infiltrates, increased crypt proliferation, and presence of neoformations. Furthermore, in the AOM/DSS model, Mal(-/-) mice had greater incidence of tumors. Mal(-/-) and WT bone marrow chimeras demonstrated that nonhematopoietic cell expression of Mal had an important protective role in the control of intestinal inflammation and inflammation-associated cancer. Mal is essential for the maintenance of intestinal homeostasis and expression of Mal in nonhematopoietic cells prevents chronic intestinal inflammation that may predispose to colon neoplasia.

[1]  L. Yu,et al.  Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis , 2014, Oncogene.

[2]  P. Fallon,et al.  A Mineral Extract from red Algae Ameliorates Chronic Spontaneous Colitis in IL‐10 Deficient Mice in a Mouse Strain Dependent Manner , 2014, Phytotherapy research : PTR.

[3]  Jochen Hampe,et al.  Functional TLR5 genetic variants affect human colorectal cancer survival. , 2013, Cancer research.

[4]  G. Trinchieri,et al.  MyD88 and its divergent toll in carcinogenesis. , 2013, Trends in immunology.

[5]  F. Carrat,et al.  Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. , 2013, Gastroenterology.

[6]  I. Grishina,et al.  MyD88 adaptor-like (Mal) functions in the epithelial barrier and contributes to intestinal integrity via protein kinase C , 2013, Mucosal Immunology.

[7]  E. Horváth-Puhó,et al.  Five-Year Mortality in Colorectal Cancer Patients with Ulcerative Colitis or Crohn's Disease: A Nationwide Population-based Cohort Study , 2013, Inflammatory bowel diseases.

[8]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[9]  E. Im,et al.  PTEN regulates TLR5‐induced intestinal inflammation by controlling Mal/TIRAP recruitment , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Belgin Dogan,et al.  Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.

[11]  M. Ciorba,et al.  Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS). , 2012, Journal of visualized experiments : JoVE.

[12]  F. Powrie,et al.  Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation , 2012, The Journal of experimental medicine.

[13]  C. Weber,et al.  Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides , 2012, Mucosal Immunology.

[14]  H. Ploegh,et al.  Accessory molecules for Toll-like receptors and their function , 2012, Nature Reviews Immunology.

[15]  R. Capasso,et al.  Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer , 2012, Journal of Molecular Medicine.

[16]  F. DiMaio,et al.  Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection , 2011, Proceedings of the National Academy of Sciences.

[17]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[18]  F. Johansen,et al.  Regulation of the polymeric immunoglobulin receptor by the classical and alternative NF-κB pathways in intestinal epithelial cells , 2011, Mucosal Immunology.

[19]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[20]  P. Hainaut,et al.  Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. , 2010, The Journal of clinical investigation.

[21]  F. Marincola,et al.  MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 , 2010, The Journal of experimental medicine.

[22]  F. Powrie,et al.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. , 2010, Gastroenterology.

[23]  H. Ford,et al.  NF-κB-mediated expression of MAPK phosphatase-1 is an early step in desensitization to TLR ligands in enterocytes , 2010, Mucosal Immunology.

[24]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[25]  Elke Cario,et al.  Toll-like receptors in inflammatory bowel diseases: A decade later , 2010, Inflammatory bowel diseases.

[26]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[27]  Philip Smith,et al.  C-Type Lectin SIGN-R1 Has a Role in Experimental Colitis and Responsiveness to Lipopolysaccharide , 2010, The Journal of Immunology.

[28]  Z. Qian,et al.  High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer , 2010, British Journal of Cancer.

[29]  Maria T. Abreu,et al.  Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function , 2010, Nature Reviews Immunology.

[30]  Douglas T. Golenbock,et al.  MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2- and TLR4-mediated NF-κB Proinflammatory Responses* , 2009, The Journal of Biological Chemistry.

[31]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[32]  D. Artis.  Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.

[33]  Markus F Neurath,et al.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.

[34]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[35]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[36]  M. Daly,et al.  The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases , 2007, Genes and Immunity.

[37]  S. Akira,et al.  NF-κB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1 , 2007, Proceedings of the National Academy of Sciences.

[38]  D. Teitelbaum,et al.  Colostomy: formation and closure , 2006 .

[39]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[40]  R. Flavell,et al.  The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors , 2002, Nature.

[41]  S. Akira,et al.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.

[42]  Dirk E. Smith,et al.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.

[43]  R. Medzhitov,et al.  TIRAP: an adapter molecule in the Toll signaling pathway , 2001, Nature Immunology.

[44]  J. Gordon,et al.  Chimeric-transgenic mice represent a powerful tool for studying how the proliferation and differentiation programs of intestinal epithelial cell lineages are regulated. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[46]  G. Trinchieri,et al.  Innate immune mechanisms of colitis and colitis-associated colorectal cancer , 2011, Nature Reviews Immunology.

[47]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[48]  R. Dysko,et al.  Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. , 2009, Journal of the American Association for Laboratory Animal Science : JAALAS.

[49]  Shizuo Akira,et al.  MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis , 2004, Journal of Gastroenterology.

[50]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .